Nothing Special   »   [go: up one dir, main page]

ZA935107B - Transdermal therapeutic system comprising the active substance 17-BETA-estradiol (anhydrous) - Google Patents

Transdermal therapeutic system comprising the active substance 17-BETA-estradiol (anhydrous)

Info

Publication number
ZA935107B
ZA935107B ZA935107A ZA935107A ZA935107B ZA 935107 B ZA935107 B ZA 935107B ZA 935107 A ZA935107 A ZA 935107A ZA 935107 A ZA935107 A ZA 935107A ZA 935107 B ZA935107 B ZA 935107B
Authority
ZA
South Africa
Prior art keywords
estradiol
beta
active substance
therapeutic system
transdermal therapeutic
Prior art date
Application number
ZA935107A
Other languages
English (en)
Inventor
Michael Horstmann
Marion Kursawe
Horst Dzekan
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA935107B publication Critical patent/ZA935107B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA935107A 1992-07-16 1993-07-15 Transdermal therapeutic system comprising the active substance 17-BETA-estradiol (anhydrous) ZA935107B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4223360A DE4223360C1 (xx) 1992-07-16 1992-07-16

Publications (1)

Publication Number Publication Date
ZA935107B true ZA935107B (en) 1994-02-04

Family

ID=6463319

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935107A ZA935107B (en) 1992-07-16 1993-07-15 Transdermal therapeutic system comprising the active substance 17-BETA-estradiol (anhydrous)

Country Status (24)

Country Link
US (1) US5997897A (xx)
EP (1) EP0650359B1 (xx)
JP (1) JP3227577B2 (xx)
KR (1) KR100281235B1 (xx)
AT (1) ATE179328T1 (xx)
AU (1) AU679450B2 (xx)
CA (1) CA2139929C (xx)
CZ (1) CZ283501B6 (xx)
DE (2) DE4223360C1 (xx)
DK (1) DK0650359T3 (xx)
ES (1) ES2133405T3 (xx)
FI (1) FI950165A (xx)
GR (1) GR3030807T3 (xx)
HR (1) HRP930991B1 (xx)
HU (1) HU221011B1 (xx)
IL (1) IL106315A (xx)
MY (1) MY111688A (xx)
NO (1) NO306378B1 (xx)
NZ (1) NZ254107A (xx)
PL (1) PL172466B1 (xx)
SI (1) SI9300387B (xx)
SK (1) SK280081B6 (xx)
WO (1) WO1994002151A1 (xx)
ZA (1) ZA935107B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL423041A1 (pl) * 2017-10-03 2019-04-08 Warszawski Univ Medyczny Nowa forma krystaliczna bezwodnego 17-ß-estradiolu, sposób jej otrzymywania oraz kompozycja farmaceutyczna zawierająca nową formę krystaliczną bezwodnego 17-ß-estradiolu i jej zastosowanie

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043731C (zh) * 1993-03-05 1999-06-23 中国人民解放军空军南京医院 治疗高血压的尼群地平贴片及其制备方法
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
WO1997020550A2 (en) * 1995-12-01 1997-06-12 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
US6238700B1 (en) 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19738856C2 (de) * 1997-09-05 2001-06-13 Lohmann Therapie Syst Lts Treibmittelfreies Verfahren zur Herstellung flächenförmiger Polymerschäume
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
AU760404B2 (en) * 2000-07-14 2003-05-15 Alchemia Oncology Pty Limited Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
CA2891537C (en) 2012-11-26 2021-02-02 Ocv Intellectual Capital, Llc Multi-axial fabrics, polymer-fiber laminates, and bodies incorporating same for connecting applications
HUP2200237A2 (hu) * 2022-06-27 2023-12-28 Pecsi Tudomanyegyetem Alacsony dózisú, stabil hatóanyag-leadású transzdermális készítmény és tapasz, valamint eljárás ezek elõállítására

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
JP2681365B2 (ja) * 1988-04-11 1997-11-26 日東電工株式会社 経皮吸収性製剤及びその製法
JPH0279792A (ja) * 1988-09-12 1990-03-20 Secoh Giken Inc 高速３相直流電動機
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL423041A1 (pl) * 2017-10-03 2019-04-08 Warszawski Univ Medyczny Nowa forma krystaliczna bezwodnego 17-ß-estradiolu, sposób jej otrzymywania oraz kompozycja farmaceutyczna zawierająca nową formę krystaliczną bezwodnego 17-ß-estradiolu i jej zastosowanie

Also Published As

Publication number Publication date
EP0650359B1 (de) 1999-04-28
CA2139929A1 (en) 1994-02-03
ES2133405T3 (es) 1999-09-16
HU221011B1 (hu) 2002-07-29
HU9403474D0 (en) 1995-02-28
KR100281235B1 (ko) 2001-02-01
ATE179328T1 (de) 1999-05-15
SK280081B6 (sk) 1999-07-12
KR950702423A (ko) 1995-07-29
CZ283501B6 (cs) 1998-04-15
NO950047L (no) 1995-01-05
DE4223360C1 (xx) 1993-04-08
NZ254107A (en) 1996-03-26
FI950165A0 (fi) 1995-01-13
MY111688A (en) 2000-11-30
JP3227577B2 (ja) 2001-11-12
DK0650359T3 (da) 1999-11-08
IL106315A0 (en) 1993-11-15
DE59309549D1 (de) 1999-06-02
SK146894A3 (en) 1996-01-10
NO950047D0 (no) 1995-01-05
CZ10695A3 (en) 1995-09-13
NO306378B1 (no) 1999-11-01
HRP930991B1 (en) 2000-02-29
WO1994002151A1 (de) 1994-02-03
JPH07508991A (ja) 1995-10-05
EP0650359A1 (de) 1995-05-03
CA2139929C (en) 2004-10-19
FI950165A (fi) 1995-01-13
HRP930991A2 (en) 1995-02-28
IL106315A (en) 1998-07-15
AU679450B2 (en) 1997-07-03
US5997897A (en) 1999-12-07
AU4565093A (en) 1994-02-14
SI9300387B (sl) 2002-02-28
GR3030807T3 (en) 1999-11-30
SI9300387A (en) 1994-03-31
PL172466B1 (pl) 1997-09-30
HUT70161A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
ZA935107B (en) Transdermal therapeutic system comprising the active substance 17-BETA-estradiol (anhydrous)
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
CA2034934A1 (en) Transdermal Therapeutic System Comprising Tulobuterol as Active Substance
IE882080L (en) Transdermal therapeutic system
NO900748D0 (no) Terapeutisk system for retardert og kontrollert transdermal eller transslimhinne administrering av aktive substanser (ii).
AU678408B2 (en) Transdermal therapeutic system for the release of 17-beta -estradiol and process for its production
HUT77085A (hu) Ösztradioltartalmú transzdermális terápiás rendszer TTS vízmegkötő adalékokkal és eljárás előállítására
IL114948A0 (en) A transdermal therapeutic system containing estradiol and a process for the preparation thereof
YU49193A (sh) Transdermalni terapijski sistem sa aktivnom materijom bezvodnim 17-beta-estradiolom